Starting therapy with cabergoline significantly delays the onset of motor complications in patients with Parkinson's disease

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1598, 2007-01, pp. : 18-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential Influences of Complementary Therapy on Motor and Non-Motor Complications in Parkinson's Disease

By Zesiewicz Theresa A.  

CNS Drugs, Vol. 23, Iss. 10, 2009-10 ,pp. : 817-835

Adis International

Access to resources Recommend Favorite

Medical Management of Levodopa-Associated Motor Complications in Patients with Parkinson's Disease

By Jankovic Joseph  

CNS Drugs, Vol. 21, Iss. 8, 2007-01 ,pp. : 677-692

Adis International

Access to resources Recommend Favorite

Motor complications, levodopa metabolism and progression of Parkinson's disease

By Müüller Thomas  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 7, 2011-07 ,pp. : 847-855

Informa Healthcare

Access to resources Recommend Favorite

Oral and Infusion Levodopa-Based Strategies for Managing Motor Complications in Patients with Parkinson's Disease

By Antonini Angelo  

CNS Drugs, Vol. 24, Iss. 2, 2010-02 ,pp. : 119-129

Adis International

Access to resources Recommend Favorite

Manage levodopa-induced motor complications in patients with Parkinson's disease with careful selection of other antiparkinsonian agents

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 1, 2008-01 ,pp. : 17-21

Adis International

Access to resources Recommend Favorite